June 3, 2019: New York, NY
New York-based Aquavit Pharmaceuticals, Inc. is delighted to introduce Dr. Jill Waibel as its new Chief Medical Officer (CMO). Jill has served as a Medical Advisor to Aquavit for five years, and is currently the Medical Director and Owner of the Miami Dermatology and Laser Institute. She is an internationally recognized leader in dermatologic laser surgery, and recently received a Cutting Edge Research Grant from the American Society for Dermatologic Surgery.
As a Medical Advisor, Waibel’s knowledge has been indispensable in fine-tuning Aquavit’s technologies. Her research experience in device assisted drug delivery made her an essential contributor to the product pipeline.
Transitioning into the role of Chief Medical Officer, Dr. Waibel will be responsible for addressing future developments in both scientific and medical aspects of current and forthcoming Aquavit products.
About Aquavit Pharmaceuticals, Inc.
Aquavit Pharmaceuticals is a multi-specialty healthcare company focused on discovering, developing and commercializing innovative pharmaceuticals, medical devices and health technologies.
For more information, visit www.aquavitpharma.com.